InsiderClue
Insiders · Profile

Schneider Eugene

EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS. Filing since 18 Jan 2023. CIK 0001838539

Company
Date
Role
Action
Shares
Amount
Of holding
IONS IONIS PHARMACEUTICALS INC
26 Jun 2026
EVP, Chf Clinical Develop Ofcr
Sold on a plan
26,000
$2.11M
25.2%
IONS IONIS PHARMACEUTICALS INC
19 Mar 2026
EVP, Chf Clinical Develop Ofcr
Sold on a plan
5,812
$412.49K
8.3%
IONS IONIS PHARMACEUTICALS INC
30 Jan 2026
EVP, Chf Clinical Develop Ofcr
Sold at will
6,179
$515.63K
8.1%
IONS IONIS PHARMACEUTICALS INC
16 Jan 2026
EVP, Chf Clinical Develop Ofcr
Sold at will
9,302
$703.14K
12.7%
IONS IONIS PHARMACEUTICALS INC
3 Sep 2025
EVP, Chf Clinical Develop Ofcr
Sold on a plan
19,658
$1.20M
27.6%
IONS IONIS PHARMACEUTICALS INC
4 Aug 2025
EVP, Chf Clinical Develop Ofcr
Sold on a plan
9,549
$408.70K
15.6%
IONS IONIS PHARMACEUTICALS INC
31 Jan 2025
EVP, Chf Clinical Develop Ofcr
Sold at will
1,484
$47.78K
2.4%
IONS IONIS PHARMACEUTICALS INC
16 Jan 2025
EVP, Chf Clinical Develop Ofcr
Sold at will
6,523
$213.89K
10.0%
IONS IONIS PHARMACEUTICALS INC
2 Feb 2024
EVP, Chf Clinical Develop Ofcr
Sold at will
2,071
$102.70K
4.0%
IONS IONIS PHARMACEUTICALS INC
17 Jan 2024
EVP, Chf Clinical Develop Ofcr
Sold at will
5,482
$276.39K
10.3%
IONS IONIS PHARMACEUTICALS INC
12 Jan 2024
EVP, Chf Clinical Develop Ofcr
Sold on a plan
8,000
$428.00K
17.3%
IONS IONIS PHARMACEUTICALS INC
26 Dec 2023
EVP, Chf Clinical Develop Ofcr
Sold on a plan
25,000
$1.29M
40.9%
IONS IONIS PHARMACEUTICALS INC
6 Feb 2023
EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
1,413
$57.46K
5.4%
IONS IONIS PHARMACEUTICALS INC
18 Jan 2023
EVP, Chf Clinical Develop Ofcr
Sold, plan not stated
4,752
$188.05K
17.5%
14 decisions on file.